Authors
Latest:
Managing Early HER2+ mBC: Patient-Centered Approaches and Evolving Treatment StrategiesExperts discuss how, it is crucial to approach treatment strategies with both compassion and transparency. It is important to explain the complexity of the situation and maintain clear and accessible language when discussing treatment strategies with patients and their families.
Latest:
Yelena Shames on Pausing Immunotherapy for Laboratory AbnormalitiesYelena Shames, MSA, ACNP-BC, CNRN, discusses when immune checkpoint inhibitor treatment should be paused because of laboratory abnormalities.
Latest:
Bridging Communication Gaps: Comprehensive Care for Upper GI Cancer TreatmentExperts discuss how to facilitate open communication among the patient, caregivers, and the multidisciplinary team to ensure comprehensive care and alignment on treatment goals.
Latest:
Advanced Care Planning: The Gift of Empowerment for Patients With CancerAdvanced care planning can benefit both the patients with cancer and the oncology nurses who work in intensive care units, as it may potentially reduce stress and moral distress.
Latest:
Palliative Care Does Not Prevent Patients From Receiving Curative TreatmentThe chair of the Institute of Pain and Palliative Care explains how the holistic approach of palliative care makes it a unique treatment modality.
Latest:
Normalize Palliative Care as Part of the Oncology Treatment PlanAdvanced practice providers play a critical role in increasing palliative care referrals.
Latest:
5 Tips for MSNs Looking to Become Nurse PractitionersStrategic tips for achieving a Nurse Practitioner certification and advancing your nursing career.
Latest:
Referral Process With Bispecifics: Challenges and SupportDr Mohan engages with Dr Mann, Nurse Brigle, Nurse Distaso, and Dr Nadeem to explore challenges in the referral process for bispecific therapy, including local health care barriers, and strategies for ensuring consistent patient education and support when care is shared between community and academic centers.
Latest:
Patient-Centered Approaches in EGFR-Mutated NSCLCPanelists discuss how oral and subcutaneous therapies have improved the quality of life for patients with EGFR-mutated advanced non–small cell lung cancer (NSCLC), with Squires sharing patient benefits from newer administration routes, and Dr Scott highlighting promising developments in EGFR-mutated NSCLC treatments, while exploring the evolving role of patient empowerment, self-management, and the multidisciplinary care team in supporting patients through home-based care and active participation in their treatment journey.
Latest:
Consistent Monitoring Is Key Post Endocrine Therapy in HR+, HER2– mBCFor patients who have progressed on endocrine therapy, consistent monitoring of blood counts and biomarker testing informs treatment sequencing.
Latest:
Future Outlooks and Next Steps in Later R/R MMPanelists discuss that shifting talquetamab dosing from weekly to every 2 weeks improves response durability and patient quality of life, while emphasizing that temporary treatment holds due to adverse effects are manageable, and ongoing research is vital to address unmet needs and advance multiple myeloma care.
Latest:
Complex Multidisciplinary Care of an AYA With Ewing SarcomaThis case demonstrates the pivotal role of a cohesive multidisciplinary team in navigating the complex care of oncology patients from diagnosis, treatment, and posttreatment surveillance.
Latest:
Supporting Patients Through Treatment for Advanced NSCLCPanelists discuss how dose modifications for ALK inhibitors can significantly improve quality-of-life issues such as brain fog and weight gain while maintaining disease control, emphasizing the importance of multidisciplinary team support, including palliative care from diagnosis.
Latest:
Case Study: Bridging the Gap for Patients With Metastatic CRCAdvanced practice providers have the opportunity to instill hope in patients through education and personalized care.
Latest:
More Than A “Side Effect”: Why Pediatric Hearing Loss Is So DetrimentalAn expert discusses the consequences of cisplatin-induced hearing loss and ongoing research efforts to eliminate this associated risk for children receiving the treatment.
Latest:
Supporting Patients Through New Breast Cancer TreatmentsThe presence of biomarkers, even in small amounts, can shape the course of treatment for a patient, says Andy Guinigundo, MSN, RN, CNP, ANP-BC.
Latest:
Navigating Difficult Conversations in Cancer Pain ManagementDifficult conversations in cancer pain management should include core values and principles, setting realistic expectations, and building the patient-client relationship from the very beginning.
Latest:
Symptom Management in CheckMate-73L TrialNagla Abdel Karim, MD, explains how researchers will address safety and manage potential adverse events in the ongoing phase 3 CheckMate-73L trial.
Latest:
Opinion: Nurses Need to Start Conversations About Genetic TestingLiz-Hunter Brack, RN, discusses how oncology nurses can play an important role in patient education surrounding genetic testing.
Latest:
Benefits, Risks With EBRT Plus SADT in Intermediate-Risk Prostate CancerIncrease in QOL and decrease in sexual function are among the benefits and risks, respectively, of adding SADT to EBRT for intermediate-risk prostate cancer.
Latest:
Zev Wainberg on Combination Chemotherapy Regimens in Metastatic Pancreatic CancerZev A. Wainberg, MD, discusses the implications of the findings from the phase 3 NAPOLI 3 trial for patients with metastatic pancreatic ductal adenocarcinoma.
Latest:
Expert Discusses Best Practices for Managing Breast Cancer–Related ToxicitiesCharles L. Loprinzi, MD, discusses the efficacy of agents like gabapentin and olanzapine to combat breast cancer treatment-related pains and speaks to the future of nonestrogenic toxicity management within this space.
Latest:
Empower Your Clinical Staff to Meet the Growing Patient VolumeOncology practices can create more access to care by leveraging the use of APPs, empowering nurses to practice at the top of their licensure, utilizing nurse navigators, and planning ahead.
Latest:
Elizabeth Cullen Discusses Avasopasem Manganese As A Potential Mucositis Management Strategy in Head and Neck CancersElizabeth R. Cullen, MSN, ARNP, provides an overview of avasopasem manganese and its potential role in reducing severe oral mucositis for patients undergoing radiotherapy.
Latest:
Medical Cannabis 101: What Oncology Nurses Need to KnowWith nearly two-thirds of the states allowing for medical cannabis use and the legalization of hemp, accessing cannabinoids has become much easier— especially for patients with cancer.
Latest:
Precision Supportive Care Centers Patient Preference in OncologyMichelle Kirschner, MSN, RN, ACNP, APRN-BC, discusses how precision supportive care tailors interventions to patient needs.
Latest:
Mary Katherine Montes de Oca on Cryocompression Therapy For Peripheral Neuropathy in Gynecologic CancersMary Katherine Montes de Oca, MD, discusses the potential benefit of cryocompression therapy in preventing peripheral neuropathy in patients with gynecologic cancers who are receiving chemotherapy.
Latest:
Advances in Head and Neck Cancers Yield New Clinical Implications for NursesAs the treatment paradigm continues to evolve, nurses play a key role in educating patients, monitoring treatments, and watching for adverse effects.
Latest:
Rx Road Map: Amivantamab (Rybrevant) Plus Lazertinib (Lazcluze)APPs provide an in-depth look at amivantamab plus lazertinib for the treatment of patients with locally advanced or metastatic non–small cell lung cancer.
